These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31058798)

  • 1. Prevalence of refractory hypertension in the United States from 1999 to 2014.
    Buhnerkempe MG; Botchway A; Prakash V; Al-Akchar M; Nolasco Morales CE; Calhoun DA; Flack JM
    J Hypertens; 2019 Sep; 37(9):1797-1804. PubMed ID: 31058798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Apparent Treatment-Resistant Hypertension in the United States According to the 2017 High Blood Pressure Guideline.
    Patel KV; Li X; Kondamudi N; Vaduganathan M; Adams-Huet B; Fonarow GC; Vongpatanasin W; Pandey A
    Mayo Clin Proc; 2019 May; 94(5):776-782. PubMed ID: 31054605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Antihypertensive Medication Use Among Individuals With a History of Stroke and Hypertension, 2005 to 2016.
    Santos D; Dhamoon MS
    JAMA Neurol; 2020 Nov; 77(11):1382-1389. PubMed ID: 32716495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive drug use and blood pressure control among stroke survivors in the United States: NHANES 2003-2014.
    Sonawane K; Zhu Y; Balkrishnan R; Suk R; Sharrief A; Deshmukh AA; Aguilar D
    J Clin Hypertens (Greenwich); 2019 Jun; 21(6):766-773. PubMed ID: 31099465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of resistant hypertension in the United States, 2003-2008.
    Persell SD
    Hypertension; 2011 Jun; 57(6):1076-80. PubMed ID: 21502568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort.
    Calhoun DA; Booth JN; Oparil S; Irvin MR; Shimbo D; Lackland DT; Howard G; Safford MM; Muntner P
    Hypertension; 2014 Mar; 63(3):451-8. PubMed ID: 24324035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant and Refractory Hypertension: Antihypertensive Treatment Resistance vs Treatment Failure.
    Siddiqui M; Dudenbostel T; Calhoun DA
    Can J Cardiol; 2016 May; 32(5):603-6. PubMed ID: 26514749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.
    Egan BM; Zhao Y; Axon RN
    JAMA; 2010 May; 303(20):2043-50. PubMed ID: 20501926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):103-8. PubMed ID: 21293325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010.
    Gu Q; Burt VL; Dillon CF; Yoon S
    Circulation; 2012 Oct; 126(17):2105-14. PubMed ID: 23091084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
    Muntner P; Carey RM; Gidding S; Jones DW; Taler SJ; Wright JT; Whelton PK
    Circulation; 2018 Jan; 137(2):109-118. PubMed ID: 29133599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.
    Tanner RM; Calhoun DA; Bell EK; Bowling CB; Gutiérrez OM; Irvin MR; Lackland DT; Oparil S; McClellan W; Warnock DG; Muntner P
    Am J Kidney Dis; 2014 May; 63(5):781-8. PubMed ID: 24388119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.
    Hajjar I; Kotchen TA
    JAMA; 2003 Jul; 290(2):199-206. PubMed ID: 12851274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the prevalence of resistant hypertension in the United States?
    Roberie DR; Elliott WJ
    Curr Opin Cardiol; 2012 Jul; 27(4):386-91. PubMed ID: 22596184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalizability of SPRINT Results to the U.S. Adult Population.
    Bress AP; Tanner RM; Hess R; Colantonio LD; Shimbo D; Muntner P
    J Am Coll Cardiol; 2016 Feb; 67(5):463-72. PubMed ID: 26562046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
    de Beus E; Bots ML; van Zuilen AD; Wetzels JF; Blankestijn PJ;
    Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.
    Khera R; Lu Y; Lu J; Saxena A; Nasir K; Jiang L; Krumholz HM
    BMJ; 2018 Jul; 362():k2357. PubMed ID: 29997129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.
    Gu Q; Burt VL; Paulose-Ram R; Dillon CF
    Am J Hypertens; 2008 Jul; 21(7):789-98. PubMed ID: 18451806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.